Skip To Main Content
Shivkar Amara on Muck Rack

Shivkar Amara

As seen in: Wiley Online Library, EIN News
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Shivkar

Contact Shivkar, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The Efficacy of Dupilumab in Pemphigus Vulgaris

|
By Shivkar Amara, Mark Lebwohl, Foday Koroma
| Wiley Online Library Verified
No abstract is available for this article.
Open in Who Shared Issue with article?

Management of Eczematous Reactions Secondary to Biologic Use in Psoriasis Patients: A Retrospective Study

|
By Shivkar Amara, Nilesh Kodali, Miyahra Lopez, Kelly Hawkins
| Wiley Online Library Verified
Conflicts of Interest Authors Amara, Lopez, Kodali, Hawkins, and Stratman declare no conflicts of interest. Author Lebwohl has received research funds on behalf of Mount Sinai from: AbbVie, Amgen, Arcutis, Avotres, Boehringer Ingelheim, Cara Therapeutics, Dermavant Sciences, Eli Lilly, Incyte, Inozyme, Janssen Research & Development LLC, Ortho Dermatologics, Pfizer, Sanofi-Regeneron, and UCB Inc. and is a consultant for Almirall, AltruBio Inc. AnaptysBio, Apogee, Arcutis Inc.
Open in Who Shared Issue with article?

Treatment with New Class of Drugs Shows Improvement in 20 Dermatological Conditions

|
By Shivkar Amara
| EIN News
Treatment with New Class of Drugs Shows Improvement in 20 Dermatological Conditions Off-label use of JAK inhibitor Upadacitinib unveils its potential for use in 20 dermatological conditions.”NEW YORK, NY, UNITED STATES, July 23, 2024 /EINPresswire.com/ -- Janus Kinase (JAK) inhibitors interfere with the JAK-STAT signaling pathway, which can correct problems of inflammation and immune function.
Open in Who Shared View Duplicates (15) Issue with article?
See all 4 articles